AI
Saturday, April 13, 2019 3:26:27 AM
Yeah, Chicago is a dead giveaway, with the number of trips NP has made to NY in the last 3 months, NYC would have made it more believable.
Also, if they had said something about cancer in the acquisition.
I mean look at this data just published a couple weeks ago, the 5 year survival rate for stage III, IV for colorectal cancer with low ccr5 expression was 70% and the high ccr5 expression just 10%, p value .001. Cytodyn holding the ccr5/cancer patents and this year being the one many in the medical field are learning of this connection, you would think they could come up with a better rumor.
https://www.nature.com/articles/s41419-019-1508-2
Also, if they had said something about cancer in the acquisition.
I mean look at this data just published a couple weeks ago, the 5 year survival rate for stage III, IV for colorectal cancer with low ccr5 expression was 70% and the high ccr5 expression just 10%, p value .001. Cytodyn holding the ccr5/cancer patents and this year being the one many in the medical field are learning of this connection, you would think they could come up with a better rumor.
https://www.nature.com/articles/s41419-019-1508-2
